Target intelligence / Profile preview

Influenza A H1N1 hemagglutinin protein

Molecular classification
Viral envelope glycoprotein
01

Overview

The hemagglutinin (HA) protein is a trimeric glycoprotein found on the surface of the influenza A virus, including the H1N1 subtype. It is essential for viral infectivity, mediating both attachment to host cells and fusion of viral and cellular membranes. HA exists as a homotrimer, with each monomer composed of two subunits: HA1 and HA2. The globular head domain (mainly HA1) contains the receptor-binding site and is highly antigenic. The stem or stalk domain (mainly HA2) anchors the protein in the viral membrane and mediates membrane fusion. Hemagglutinin is highly immunogenic; it stimulates neutralizing antibody responses that are central to vaccine efficacy. Antigenic drift (mutation) or shift (reassortment) in this protein can lead to immune escape or pandemics. Determines species specificity by recognizing different linkages of sialic acid residues present on avian versus mammalian cells. Plays a major role in virulence; mutations affecting its stability or activation pH can alter transmissibility and pathogenicity. Hemagglutination inhibition assays measure antibodies against this protein as a correlate of immunity/vaccine response. Recombinant forms are widely used for research, diagnostics, vaccine development, and structural studies.

02

Mechanism of action

Hemagglutinin is the target of neutralizing antibodies, preventing viral entry and infection.

03

Biological functions

Receptor bindingMembrane fusionViral entry
04

Disease associations

Infection
05

Safety considerations

Antigenic drift and shift can lead to immune escape.Mutations can affect transmissibility and pathogenicity.

Beyond the preview

Go deeper on Influenza A H1N1 hemagglutinin protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A H1N1 hemagglutinin protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call